Vaxcyte, Inc. (PCVX)
63.62
-1.65
(-2.53%)
USD |
NASDAQ |
Oct 16, 16:00
63.25
-0.37
(-0.58%)
After-Hours: 20:00
Vaxcyte Net Income (TTM) : -1.064B for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.064B |
| March 31, 2026 | -946.53M |
| December 31, 2025 | -766.63M |
| September 30, 2025 | -657.20M |
| June 30, 2025 | -547.50M |
| March 31, 2025 | -509.62M |
| December 31, 2024 | -463.93M |
| September 30, 2024 | -507.65M |
| June 30, 2024 | -497.19M |
| March 31, 2024 | -436.82M |
| December 31, 2023 | -402.27M |
| September 30, 2023 | -299.52M |
| June 30, 2023 | -264.77M |
| March 31, 2023 | -244.96M |
| Date | Value |
|---|---|
| December 31, 2022 | -223.48M |
| September 30, 2022 | -174.00M |
| June 30, 2022 | -142.70M |
| March 31, 2022 | -117.84M |
| December 31, 2021 | -100.08M |
| September 30, 2021 | -92.25M |
| June 30, 2021 | -86.65M |
| March 31, 2021 | -83.30M |
| December 31, 2020 | -89.22M |
| September 30, 2020 | -83.10M |
| June 30, 2020 | -73.40M |
| March 31, 2020 | -63.74M |
| December 31, 2019 | -50.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Vir Biotechnology, Inc. | -251.68M |
| Revolution Medicines, Inc. | -1.768B |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |